JPRN-UMIN000026130已完成未知
Research on Advanced Intervention using Novel Bone marrOW stem cell (RAINBOW): Phase I, open-label, uncontrolled, dose-response trial of autologous bone marrow stromal cell transplantation in patients with acute ischemic stroke - RAINBOW trial
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 7
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •First screening 1) Occurrence of a severe hemorrhagic transformation of ischemic stroke 2) Subjects with deep coma or coma evaluated by Japan Coma Scale (JCS; 300 or 200) 3) Severe anemia (hemoglobin<10.0 g/dL) or thrombocytopenia (platelet count <100,000/mm^3) 4) Severe heart disease (e.g. ischemic heart disease, heart failure) 5) Significant abnormal laboratory tests; a. >3 x ULN for alanine aminotransferase or aspartate aminotransferase b. >1.5 x ULN for total bilirubin c. >1.5 x ULN for serum creatinine 6) Uncontrolled hypertension, despite antihypertensive therapy 7) History of malignancy of any type 8) Carriers of infectious disease as follows: Syphilis, hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV)-1/2, human T cell leukemia virus (HTLV)-1, or parvovirus B19 9) Subjects who are during pregnancy or want to have children 10) Lactating women 11) Fertile Women who are unable to practice contraception 12) History of seizure or administration of any antiepileptic drugs 13) Contraindication for taking fosphenytoin sodium hydrate 14) Serious allergy to any possible residues in the test product (e.g. any biomaterials used in manufacturing process, gentamicin sulfate, ferucarbotran) or any agents used for the administration of the test product or any inspections during the trial 15) Contraindication for MRI (e.g. a pacemaker, metallic artificial heart valves, an implantable cardioverter defibrillator) 16)Subjects who participate in other clinical trial within 90 days before enrollment. 17) Subjects who are improper on the basis of the judgement by primary investigator or other investigators. Second screening 1-6) The same criteria at first screening 7) Subjects who are improper on the basis of the judgement by primary investigator or other investigators
研究者
相似试验
招募中
不适用
A new method for the treatment of intractable bony ankylosis of the temporomandibular joint utilizing intentional pseudoarthrosisbony ankylosis of the temporomandibular jointJPRN-UMIN000041958Kyorin University School of Medicine4
招募中
不适用
Proposal of treatment systematization for Benign Bone Tumors comparing different techniques in different forms of presentatioBenign bone neoplasmsD16.2D16.0RBR-9c4jxpniversidade de São Paulo
已完成
不适用
A clinical study to evaluate the efficacy of bone-modyfying agent for the patients of prostate cancer.prostate cancerJPRN-UMIN000015126Department of Urology, Keio University School of Medicine
尚未招募
不适用
Research of the utility of newly developed implant system (Octafix)JPRN-UMIN000006183Department of Dentistry and Oral Surgery,Shinsyu University School of Medicine50
未知
不适用
Development of the new rehabilitation method for jaw deformity patients.Jaw deformityJPRN-UMIN000024966Tokushima univercity150